A new study published in the Journal of the American Heart Association on Wednesday, has concluded that breastfeeding is not only healthy for babies, but may also reduce a mother’s risk of having a heart attack or stroke later in life.

The approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has generated a mix of excitement and concern among health experts. While the innovation is seen as a major advancement in the global fight against HIV, its cost is raising alarms about equitable access, particularly for low-income countries. The United States Food and Drug Administration (FDA) recently gave the green light Lenacapavir, the drug margeted as Yeztugo, which is designed to prevent HIV infection when administered every six months. It has been found highly effective in reducing new infections, offering a simpler alternative to daily oral PrEP pills like Truvada and Descovy, or bimonthly options like Apretude.

A remarkable two-decade wait has finally ended for one couple. Doctors at Columbia University Fertility Center have reported the first-ever pregnancy achieved using a groundbreaking artificial intelligence (AI) system, offering new hope to couples struggling with male infertility. In a pioneering advancement, Columbia’s fertility specialists announced the first successful pregnancy using the STAR (Sperm Tracking and Recovery) system, an AI-based procedure designed to identify and isolate viable sperm in cases of azoospermia, a condition marked by the absence of detectable sperm in a man’s ejaculate.